These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2446487)

  • 1. Medical management of malignant pericardial effusion by tetracycline sclerosis.
    Shepherd FA; Morgan C; Evans WK; Ginsberg JF; Watt D; Murphy K
    Am J Cardiol; 1987 Nov; 60(14):1161-6. PubMed ID: 2446487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade.
    Maher EA; Shepherd FA; Todd TJ
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):637-43. PubMed ID: 8800150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetracycline sclerosis in the management of malignant pericardial effusion.
    Shepherd FA; Ginsberg JS; Evans WK; Scott JG; Oleksiuk F
    J Clin Oncol; 1985 Dec; 3(12):1678-82. PubMed ID: 4067615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subxiphoid partial pericardiectomy with or without sclerosant instillation in the treatment of symptomatic pericardial effusions in patients with malignancy.
    Chan A; Rischin D; Clarke CP; Woodruff RK
    Cancer; 1991 Sep; 68(5):1021-5. PubMed ID: 1913473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapericardial minocycline sclerosis for malignant pericardial effusion.
    Lashevsky I; Ben Yosef R; Rinkevich D; Reisner S; Markiewicz W
    Chest; 1996 Jun; 109(6):1452-4. PubMed ID: 8769492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases.
    Davis S; Rambotti P; Grignani F
    J Clin Oncol; 1984 Jun; 2(6):631-6. PubMed ID: 6726303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients.
    Celermajer DS; Boyer MJ; Bailey BP; Tattersall MH
    Med J Aust; 1991 Jan; 154(1):19-22. PubMed ID: 1701847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy.
    Tsang TS; Seward JB; Barnes ME; Bailey KR; Sinak LJ; Urban LH; Hayes SN
    Mayo Clin Proc; 2000 Mar; 75(3):248-53. PubMed ID: 10725950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade.
    Tomkowski WZ; Wiśniewska J; Szturmowicz M; Kuca P; Burakowski J; Kober J; Fijałkowska A
    Support Care Cancer; 2004 Jan; 12(1):53-7. PubMed ID: 14505155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions.
    Wang HJ; Hsu KL; Chiang FT; Tseng CD; Tseng YZ; Liau CS
    Chest; 2002 Sep; 122(3):893-9. PubMed ID: 12226029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of malignant pericardial effusion with instillation of mitomycin C in non-small cell lung cancer.
    Kaira K; Takise A; Kobayashi G; Utsugi M; Horie T; Mori T; Imai H; Inazawa M; Mori M
    Jpn J Clin Oncol; 2005 Feb; 35(2):57-60. PubMed ID: 15709087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapericardial cisplatin administration after pericardiocentesis in patients with lung adenocarcinoma and malignant cardiac tamponade.
    Bischiniotis TS; Lafaras CT; Platogiannis DN; Moldovan L; Barbetakis NG; Katseas GP
    Hellenic J Cardiol; 2005; 46(5):324-9. PubMed ID: 16295940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchopericardial fistula, an unusual complication of oxytetracycline sclerosis therapy.
    Grbolar A; Qaradaghi L; Imren Y; Tasoglu I; Coskun E; Avci T
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):280-1. PubMed ID: 18073228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter drainage followed by the instillation of bleomycin to manage malignant pericardial effusion in non-small cell lung cancer: a multi-institutional phase II trial.
    Maruyama R; Yokoyama H; Seto T; Nagashima S; Kashiwabara K; Araki J; Semba H; Ichinose Y
    J Thorac Oncol; 2007 Jan; 2(1):65-8. PubMed ID: 17410012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous catheter drainage for malignant pericardial effusion.
    Gatenby RA; Hartz WH; Kessler HB
    J Vasc Interv Radiol; 1991 Feb; 2(1):151-5. PubMed ID: 1799745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pericardial effusion in patients with malignant neoplasms].
    Beretta F; Martinelli G; Cavalli F; Marone C
    Schweiz Med Wochenschr; 1992 Oct; 122(41):1517-23. PubMed ID: 1411410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of percutaneous interventions for malignant pericardial effusion.
    Virk SA; Chandrakumar D; Villanueva C; Wolfenden H; Liou K; Cao C
    Heart; 2015 Oct; 101(20):1619-26. PubMed ID: 26180077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of malignant pericardial effusion.
    Vaitkus PT; Herrmann HC; LeWinter MM
    JAMA; 1994 Jul; 272(1):59-64. PubMed ID: 8007081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of malignant pericardial effusion].
    Hosomi Y; Ohkuma Y; Shibuya M
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):906-9. PubMed ID: 18633218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to the management and treatment of malignant pericardial effusion.
    Tomkowski W; Szturmowicz M; Fijałkowska A; Burakowski J; Filipecki S
    Support Care Cancer; 1997 Jan; 5(1):64-6. PubMed ID: 9010992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.